logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

Mirati: Q2 Earnings Snapshot

By AP News - Aug 08, 2023, 05:00 PM ET
Last Updated - May 06, 2024, 11:14 AM EDT
MRTX_Logo
The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $3.23 per share

Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $176.9 million in its second quarter

SAN DIEGO (AP) — SAN DIEGO (AP) — Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $176.9 million in its second quarter. 

On a per-share basis, the San Diego-based company said it had a loss of $3.04. 

Sponsored

The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $3.23 per share. 

The biopharmaceutical company posted revenue of $13.7 million in the period, which fell short of Street forecasts. Seven analysts surveyed by Zacks expected $13.9 million. 

_____ 

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a MRTX">Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415